167 related articles for article (PubMed ID: 32983938)
1. Flavones scaffold of
Kikiowo B; Ogunleye AJ; Inyang OK; Adelakun NS; Omotuyi OI; Metibemu DS; David TI; Oludoyi OO; Ijatuyi TT
Bioimpacts; 2020; 10(4):227-234. PubMed ID: 32983938
[No Abstract] [Full Text] [Related]
2. Cleroda-4(18),13-dien-15,16-olide as novel xanthine oxidase inhibitors: An integrated in silico and in vitro study.
Nguyen HT; Vu TY; Dakal TC; Dhabhai B; Nguyen XHQ; Tatipamula VB
PLoS One; 2021; 16(6):e0253572. PubMed ID: 34191831
[TBL] [Abstract][Full Text] [Related]
3. Standardization and xanthine oxidase inhibitory potential of Zanthoxylum armatum fruits.
Ranjana ; Nooreen Z; Bushra U; Jyotshna ; Bawankule DU; Shanker K; Ahmad A; Tandon S
J Ethnopharmacol; 2019 Feb; 230():1-8. PubMed ID: 30342965
[TBL] [Abstract][Full Text] [Related]
4. Study on the interaction mechanism between luteoloside and xanthine oxidase by multi-spectroscopic and molecular docking methods.
Chen J; Wang Y; Pan X; Cheng Y; Liu J; Cao X
J Mol Recognit; 2022 Dec; 35(12):e2985. PubMed ID: 35907782
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of
Kikiowo B; Ogunleye JA; Iwaloye O; Ijatuyi TT
J Biomol Struct Dyn; 2022 Mar; 40(4):1801-1812. PubMed ID: 33054572
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and xanthine oxidase inhibitory activity of 7-methyl-2-(phenoxymethyl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one derivatives.
Sathisha KR; Khanum SA; Chandra JN; Ayisha F; Balaji S; Marathe GK; Gopal S; Rangappa KS
Bioorg Med Chem; 2011 Jan; 19(1):211-20. PubMed ID: 21163661
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore modeling, molecular docking and molecular dynamics studies on natural products database to discover novel skeleton as non-purine xanthine oxidase inhibitors.
Peng J; Li Y; Zhou Y; Zhang L; Liu X; Zuo Z
J Recept Signal Transduct Res; 2018 Jun; 38(3):246-255. PubMed ID: 29843539
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidase inhibitory activity of natural and hemisynthetic flavonoids from Gardenia oudiepe (Rubiaceae) in vitro and molecular docking studies.
Santi MD; Paulino Zunini M; Vera B; Bouzidi C; Dumontet V; Abin-Carriquiry A; Grougnet R; Ortega MG
Eur J Med Chem; 2018 Jan; 143():577-582. PubMed ID: 29207340
[TBL] [Abstract][Full Text] [Related]
10. Xanthine oxidoreductase and its inhibitors: relevance for gout.
Day RO; Kamel B; Kannangara DR; Williams KM; Graham GG
Clin Sci (Lond); 2016 Dec; 130(23):2167-2180. PubMed ID: 27798228
[TBL] [Abstract][Full Text] [Related]
11. Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure-activity relationship and molecular docking studies (2018-2024).
Singh A; Debnath R; Chawla V; Chawla PA
RSC Med Chem; 2024 Jun; 15(6):1849-1876. PubMed ID: 38911168
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 2-phenylthiazole-4-carboxylic acid, a novel and potent scaffold as xanthine oxidase inhibitors.
Xu X; Deng L; Nie L; Chen Y; Liu Y; Xie R; Li Z
Bioorg Med Chem Lett; 2019 Feb; 29(4):525-528. PubMed ID: 30630716
[TBL] [Abstract][Full Text] [Related]
13. Molecular Docking Analysis of Selected Clinacanthus nutans Constituents as Xanthine Oxidase, Nitric Oxide Synthase, Human Neutrophil Elastase, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9 and Squalene Synthase Inhibitors.
Narayanaswamy R; Isha A; Wai LK; Ismail IS
Pharmacogn Mag; 2016 Jan; 12(Suppl 1):S21-6. PubMed ID: 27041853
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the inhibition effect of thymoquinone on xanthine oxidase activity using differential pulse voltammetry in combination with theoretical studies.
Rezaeinasab M; Benvidi A; Gharaghani S; Abbasi S; Zare HR
Enzyme Microb Technol; 2019 Feb; 121():29-36. PubMed ID: 30554642
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment.
Knake C; Stamp L; Bahn A
Biochem Biophys Res Commun; 2014 Sep; 452(1):157-62. PubMed ID: 25152400
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
Sato D; Kisen T; Kumagai M; Ohta K
Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Xanthine Oxidase: Scaffold Diversity and Structure-Based Drug Design.
Luna G; Dolzhenko AV; Mancera RL
ChemMedChem; 2019 Apr; 14(7):714-743. PubMed ID: 30740924
[TBL] [Abstract][Full Text] [Related]
18. Fast dereplication of xanthine oxidase-inhibiting compounds in alfalfa using comparative metabolomics.
Hsu SJ; Verpoorte R; Lin SM; Lee CK
Food Res Int; 2021 Mar; 141():110170. PubMed ID: 33642026
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
